Caas Capital Management LP Edwards Lifesciences Corp Put Options Transaction History

Caas Capital Management LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Oct 28, 2024	BUY	$59.7 - $93.78 $722,370 - $1.13 Million	12,100 New	12,100 $798,000
Q1 2024 Apr 26, 2024	SELL	$72.54 - $95.56 $159,588 - $210,232	-2,200 Reduced 17.6%	10,300 $984,000
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $98,736 - $124,416	1,600 Added 14.68%	12,500 $953,000
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $62,352 - $84,042	900 Added 9.0%	10,900 $755,000
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $716,408 - $830,104	8,800 Added 733.33%	10,000 $943,000
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $89,112 - $101,412	1,200 New	1,200 $99,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.